PF-AtlasDrugs › Sotatercept

Sotatercept

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
Amsterdam UMC, location VUmc

Overview

Sotatercept is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

Sotatercept clinical trials

Explore related

Medical disclaimer. This page summarizes research about Sotatercept for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.